Want to see FZMD full AI Analyst Report?
Fuse Medical (FZMD) AI Stock Analysis
Fuse Medical
(Other OTC:FZMD)
No summary available
Fuse Medical (FZMD) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $2.22M
- Dividend Yield
- ―
- Average Volume (3M)
- 47.43K
- Price to Earnings (P/E)
- 15.0
- Beta (1Y)
- -1.42
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- US
- Employees
- 31
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Fuse Medical Business Overview & Revenue Model
Company Description
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal...
How the Company Makes Money
Fuse Medical generates revenue primarily through the sale and distribution of its orthopedic and spine-related medical products. Their revenue model relies on direct sales to healthcare providers, hospitals, and surgical centers. Key revenue streams...
Fuse Medical Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FZMD, the sentiment is Negative. The current price of 0.03 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 37.59 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FZMD.
Fuse Medical Risk Analysis
Fuse Medical disclosed 32 risk factors in its most recent earnings report. Fuse Medical reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksFuse Medical Peers Comparison
Overall Rating
AEMD58Neutral
PAVM42Neutral
NUWE40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AEMD | 58Neutral | $8.73M | -0.46 | -123.09% | ― | ― | 87.54% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| PAVM | 42Neutral | $15.59M | -0.12 | -33.51% | ― | -89.02% | -107.75% |
| NUWE | 40Underperform | $3.07M | -0.00 | -605.75% | ― | 8.36% | 88.88% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FZMD | Fuse Medical | 0.03 | -0.05 | -67.11% | |
| NUWE | Nuwellis, Inc. | 5.68 | -866.37 | -99.35% | |
| AEMD | Aethlon | 5.44 | -19.16 | -77.89% | |
| PAVM | Pavmed | 1.95 | -10.05 | -83.75% | |
| BBLG | Bone Biologics Corp | 0.38 | -1.66 | -81.37% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.